Susan E. Siegel - 25 May 2023 Form 4 Insider Report for NEVRO CORP

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Susan E. Siegel
Issuer symbol
N/A
Transactions as of
25 May 2023
Net transactions value
$0
Form type
4
Filing time
30 May 2023, 17:28:15 UTC
Previous filing
19 May 2023
Next filing
31 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +6,754 +125% $0.000000 12,164 25 May 2023 Direct F1, F2
holding NVRO Common Stock 628 25 May 2023 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs shall vest on the earlier of (i) one year anniversary of May 25, 2023 or (ii) the next Annual Meeting following May 25, 2023, subject to the Reporting Person's continued service to the Issuer.
F2 Includes 7,381 RSUs.
F3 Shares held by Bob Reed and Susan Siegel as trustees of the Reed-Siegal Revocable Trust.